INDUSTRY
Discover how we're helping companies deliver better patient outcomes through differentiated platforms, consulting, and operations services
STARTUPS: APPLY NOW FOR THE HEALTHTECH INNOVATION CHALLENGE
Tackling the world’s biggest health issues together.
Life sciences is evolving rapidly from selling products to delivering value through better patient outcomes.
We work with our pharmaceutical, biotech, medical technology, distributor and consumer health clients globally to redefine the future of the life sciences industry: combining the latest technology with scientific breakthroughs to revolutionize how medical treatments are discovered, developed and delivered to patients around the world.
New science: Biopharma’s new growth engine
Biopharma is facing compressive disruption that could impact traditional approaches. Find out how New Science can reshape the biopharma landscape and deliver better patient outcomes.
READ MOREAccenture's video shows how New Science can reshape the biopharma landscape and patient care to overcome compressive disruption. See more.
View TranscriptAccenture Life Sciences offers a full range of services in Strategy, Consulting, Accenture Interactive, Operations and Technology that help deliver more personalized healthcare and better patient outcomes.
Accenture helped a biopharma company implement a patient-centered platform to manage the delivery of a personalized gene therapy solution.
A new SAP S/4 HANA ERP solution ushers Merck KGaA Healthcare into a digital future.
Roche's NAVIFY® Tumor Board is changing the way tumor board meetings are organized.
Accenture surveyed 128 life sciences industry leaders to better understand digital transformation in the lab.
Learn three steps biopharma marketers can take to drive growth.
To tackle new challenges, medical-device makers will have to take a whole new approach to innovation.
Our Life Sciences solutions are helping businesses deliver exceptional patient experiences. Discover how our awards distinguish us as an industry leader.
Everest Group PEAK Matrix Report
2019
Recognized by Frost & Sullivan
2018 Recipient
Recognized by IDC MarketScape
2018 Recognition
We are proud to collaborate with leading women in life sciences in their quest to advance science and patient care.
Dr. Saori Watanabe Miyano of Eisai’s Tsukuba Research Laboratories is Senior Director of the Oncology Tsukuba Research Department that spearheads the company’s cancer research. Interested in biology and chemistry at high school and wanting to learn about these subjects in greater depth, she went on to study pharmacology at university. She considered becoming a pharmacist, devoted to helping the patients she encountered in person, or a drug development scientist, so that she could provide better drugs for patients all over the world. Having considered her options, she chose a path that led her to the Tsukuba Research Department at Eisai. Having gained experience as a researcher and steadily advanced in her career, Dr. Watanabe became a Senior Director of the Oncology Business Group in Japan and now heads a team of some 20 scientist. Maintaining regular contact with colleagues at Eisai’s overseas laboratories, she plays a prominent role as one of the company’s female leaders.
Life Sciences consultants weigh in on how pharma, biotech, medtech and consumer health companies can improve patient outcomes.
Learn more about what’s happening within the life sciences laboratory.
As companies use data to anticipate customer needs, it makes sense that customer expectations will no longer recognize traditional boundaries.
Accenture and Google Cloud announced that Google Cloud will be the cloud technology provider for Accenture’s INTIENT™ life sciences industry platform.
Accenture and UCB, a global biopharmaceutical company, have collaborated to build a safety solution with Accenture’s INTIENT™ Pharmacovigilance.
